期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

吸入性糖皮质激素治疗哮喘相关专利申请剂型分析 被引量：1

Analysis of Patents about Inhaled Corticosteroid in the Treatment of Asthma
下载PDF
导出
摘要 吸入型糖皮质激素（ICS）是目前治疗哮喘中应用最广泛、最主要的抗炎药物.本文对ICS治疗哮喘相关专利申请剂型进行分析,以期为相关研究者提供有价值的专利信息,力求服务于我国相关技术的研发与创新. Inhaled corticosteroid （ICS） is the most widely used and most important anti - inflammatory drug in the treatment of asthma. This paper analyzed the dosage forms of ICS for asthma related patents, in order to provide valuable patents information for relevant researchers, and strive to serve the R ＆ D and innovation of related technologies in China.
作者 刘应梅 辛雪 LIU Yingmei;XIN Xue(Patent Examination Cooperation Sichuan Center of the Patent Office, SIPO, Chengdu Sichuan 610213)
机构地区 国家知识产权局专利局专利审查协作四川中心
出处 《河南科技》 2018年第9期50-52,共3页 Henan Science and Technology
关键词 吸入性糖皮质激素 哮喘 专利 Inhaled corticosteroid asthma patent
分类号 R94 [医药卫生—药剂学]
  • 相关文献

参考文献3

二级参考文献50

  • 1Laube BL, Janssens HM, de Jongh FH, et al. What thepulmonary specialist should know about the new inhalationtherapies. ERS/ISAM task force report [J]. Eur Respir J,2011,37(6):1308-1331.
  • 2金方、侯曙光译,呼吸道药物递送的基本理论与实践[M].北京:化学工业出版社,2011: 222-223.
  • 3Clarke MJ, Bynm J,Taniforth N. Physicochemical factorsgoverning the performance of nedocromil sodium as a powderaerosol[J]. J Pharm Sci, 2000,89(9):1160-1169.
  • 4郑昕,LouiseR,陈昱,等.含福莫特罗的MDI的研究进展[J].国际医药商情,2012,12:28-30.
  • 5Cazzola M, Spina D, Matera MG. The use of bronchodilatorsin stable chronic obstructive pulmonary disease[J]. PulmPharmaco Ther, 1997,10(3):129-144.
  • 6Laforce C, Aunlann J, de Teresa Parrefiol, et al. Sustained 24-hour efficacy of once daily indacaterol(300mug)in patientswith chronic obstructive pulmonary disease: A randomized,crossover study[J]. Pulm Pharmaco Ther, 2011, 24(1):162-168.
  • 7Vail Ncord J, Smeets J, Drenth B, et al. 24-hour bronchodilationfollowing a single dose of the novel beta 2-agonist oiodatcrol inCOPD[J]. Pulm Pharmaco Ther, 2011, 24(6):666-672.
  • 8Maltais F, Celli B, Casaburi, et al. Aclidinium bromideimproves exercise endurance and lung hyper inflation inPatients with moderate to severe COPD[J]. Respir Med, 2011,105(4):580-587.
  • 9Vogelmeier CF, Hering F, Lewin R, et al. Efficacy and safetyof ciclesonide in the treatment of 24,037 asthmatic patients inroutine medical care[J]. Respir Med, 2011, 105(2):186-194.
  • 10Mark JC, Chuang TT, Harris CA, et al. Increased expression OfG-protein coupled receptor kinases in cystic fibrosis lung[J]. EurJ Pharmaco, 2002, 436(3): 165-172.

共引文献56

同被引文献9

引证文献1

河南科技
2018年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部